SARS-CoV 2
Showing 26 - 50 of 95
COVID-19, SARS-CoV 2 Trial in Sioux Falls (Hydroxychloroquine, Vitamin D)
Terminated
- COVID-19
- SARS-CoV 2
- Hydroxychloroquine
- Vitamin D
-
Sioux Falls, South DakotaSanford Health
Dec 8, 2021
Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare
Completed
- SARS-CoV 2
- Throat swab sample for measuring current infection with SARS-CoV-2
- Blood sample for serology to measure past infection with SARS-CoV-2
-
Stockholm, SwedenKarolinska University Hospital
Dec 2, 2021
Covid19, SARS-CoV 2, Coronavirus Infection Trial in Madrid (Melatonin 2mg, Placebo oral tablet)
Completed
- Covid19
- +2 more
- Melatonin 2mg
- Placebo oral tablet
-
Madrid, SpainHospital Universitario La Paz
Nov 22, 2021
Network-Targeted Strategies for Efficient Community SARS-CoV-2
Enrolling by invitation
- COVID-19
- SARS-CoV 2
-
Durham, North CarolinaMargaret Pendzich
Nov 15, 2021
Severity of Venous Thromboembolism inGeneral Population During
Completed
- COVID-19
- +4 more
- Diagnostic examination for venous thromboembolism
-
Linköping, Östergötland, SwedenUniversity Hospital Linköping
Nov 17, 2021
COVID-19, SARS-CoV 2 Trial in United States (Hydroxychloroquine (HCQ), Azithromycin (Azithro), Placebo for Hydroxychloroquine)
Terminated
- COVID-19
- SARS-CoV 2
- Hydroxychloroquine (HCQ)
- +3 more
-
Birmingham, Alabama
- +10 more
Nov 12, 2021
Corona Virus Infection, Middle East Respiratory Syndrome (MERS), Acute Respiratory Distress Syndrome Trial in Cairo (Lactoferrin
Not yet recruiting
- Corona Virus Infection
- +5 more
- Lactoferrin (Apolactoferrin)
- Placebo of excipient(s) will be administered
-
Cairo, Giza, Egypt
- +3 more
Nov 12, 2021
COVID-19, Corona Virus Infection, SARS-CoV 2 Trial in Toronto (Methylene-Blue Photodisinfection)
Completed
- COVID-19
- +2 more
- Methylene-Blue Photodisinfection
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Oct 29, 2021
Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare
Enrolling by invitation
- SARS-CoV 2
- SARS-CoV2 antibody measurement
-
Stockholm, SwedenKarolinska University Hospital
Oct 21, 2021
SARS-CoV 2, COVID-19 Trial in Manama (Hydroxychloroquine, Favipiravir, Routine care for COVID-19 patients)
Completed
- SARS-CoV 2
- COVID-19
- Hydroxychloroquine
- +2 more
-
Manama, BahrainRoyal College of Surgeons in Ireland - Bahrain
Oct 25, 2021
SARS-CoV 2, COVID-19 Trial in Manama (plasma therapy using convalescent plasma with antibody against SARS-CoV-2, Routine care
Completed
- SARS-CoV 2
- COVID-19
- plasma therapy using convalescent plasma with antibody against SARS-CoV-2
- Routine care for COVID-19 patients
-
Manama, BahrainRoyal College of Surgeons in Ireland - Bahrain
Oct 25, 2021
COVID-19 (SARS-CoV-2) in Urine and Semen
Completed
- SARS-CoV 2
- +4 more
- SARS-CoV 2 RNA PCR Urine
- +7 more
-
Florence, Tuscany, ItalyAOU Careggi
Oct 8, 2021
COVID-19 Survival - The COVIVA Study
Completed
- COVID-19
- SARS-CoV 2
-
Basel, SwitzerlandUniversity Hospital Basel
Oct 4, 2021
COVID-19 Biorepository
Recruiting
- Covid-19
- +3 more
-
Kansas City, KansasUniversity of Kansas Medical Center
Sep 28, 2021
SARS-COV 2, Covid19 Trial (5-ALA-Phosphate + SFC (5-ALA+SFC))
Withdrawn
- SARS-COV 2
- Covid19
- 5-ALA-Phosphate + SFC (5-ALA+SFC)
- (no location specified)
Sep 15, 2021
COVID-19, SARS-CoV 2 Trial in Orlando (Seraph®-100 Microbind® Affinity Blood Filter)
Enrolling by invitation
- COVID-19
- SARS-CoV 2
- Seraph®-100 Microbind® Affinity Blood Filter
-
Orlando, FloridaAdventHealth Orlando
Sep 13, 2021
WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical
Completed
- COVID
- +2 more
- Equipment with smartwatch throughout hospital stay on the general ward
-
Bern, SwitzerlandEmergency Department, University Hospital Bern, Inselspital
Aug 25, 2021
COVID19 Neurological Manifestation
Completed
- SARS-CoV 2
- Neurologic Manifestations
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Aug 13, 2021
COVID, Coronavirus Infection, SARS-CoV 2 Trial in Bogotá (P2Et (Caesalpinia spinosa extract), Placebo)
Recruiting
- COVID
- +3 more
- P2Et (Caesalpinia spinosa extract)
- Placebo
-
Bogotá, ColombiaHospital Universitario San Ignacio
Aug 6, 2021
COVID-19, SARS-CoV 2, SARS-CoV Infection Trial in Newark (COVID-19 Convalescent Plasma)
Available
- COVID-19
- +2 more
- COVID-19 Convalescent Plasma
-
Newark, New Jersey
- +1 more
Jul 29, 2021
SARS-CoV 2, SARS Trial in Córdoba (Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA], Sarilumab 400 MG/2.28 ML
Completed
- SARS-CoV 2
- SARS
- Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]
- +2 more
-
Córdoba, SpainHospital Universitario Reina Sofía
Jul 6, 2021
COVID, Covid-19, SARS-CoV 2 Trial (Symptoms entered into the CovidX application)
Withdrawn
- COVID
- +2 more
- Symptoms entered into the CovidX application
- (no location specified)
Jun 28, 2021
Disorders in Family Members of COVID-19 Patients Admitted to ICU
Completed
- Respiratory Failure
- +7 more
-
Aurora, Colorado
- +8 more
Jun 18, 2021